Newswise — Welcome to the August 2019 edition of Beth Israel Deaconess Medical Center’s (BIDMC) Research & Health News Digest.

This edition’s update includes:

  • Trigger warning: One to two servings of caffeinated beverages not associated with higher risk of migraine headaches, but three or more may trigger migraines (General Health)
  • Study: Non-invasive electrical stimulation alters blood flow in brain tumors (Neurology)
  • New data indicate rise in opioid use for migraine treatment (Pain Management)
  • How to avoid migraine triggers (Pain Management)
  • Treating chronic pain with integrative therapies (Pain Management)
  • Revisits have increased since implementation of program intended to reduce hospital readmissions (Health Care Policy)
  • BIDMC prostate health experts available for interview during National Prostate Health Month
  • BIDMC pain experts available for interview during National Pain Awareness Month

If any of these briefs pique your interest and you’d like to speak with one of our experts, please contact us at [email protected] or at 617-667-7300. You can also reach the BIDMC communications team member on call through the BIDMC page operator at (617) 667-4700 by asking for pager ID #33880.

The BIDMC Media Relations Team

BIDMC Research & Health News Digest: August 2019

Trigger Warning: One to Two Servings of Caffeinated Beverages Not Associated with Higher Risk of Migraine Headaches, but Three or More May Trigger Migraines

Researchers led by Elizabeth Mostofsky, ScD, an investigator in BIDMC’s Cardiovascular Epidemiology Research Unit, evaluated the role of caffeinated beverages as a potential trigger of migraine. The findings, published in the American Journal of Medicine, reveal that among patients who experience episodic migraine, one to two servings of caffeinated beverages were not associated with headaches on that day – but three or more servings of caffeinated beverages may be associated with higher odds of migraine headache occurrence on that day or the following day.


Study: Non-invasive Electrical Stimulation Alters Blood Flow in Brain Tumors

In a first-of-its kind study, neurologists at BIDMC tested the use of non-invasive electrical stimulation as a novel therapeutic approach to brain tumors. In an experiment published in Science Advances, the scientists – led by Emiliano Santarnecchi, PhD, principal investigator at the Berenson-Allen Center For Non-Invasive Brain Stimulation at BIDMC – demonstrated that applying low-intensity electrical stimulation to the brains of patients with tumors resulted in decreased blood flow within tumors while leaving the rest of the brain unchanged. Although further study is needed, the findings suggest that a series of such treatments could modify tumor growth and progression.


New Data Indicate Rise in Opioid Use for Migraine Treatment

An increasing number of Americans are using opioids to treat their migraine headaches, despite the fact that opioids are not the recommended first-line therapy for migraine in most cases. That’s according to the ObserVational Survey of the Epidemiology, tReatment and Care Of MigrainE (OVERCOME) study, a web-based patient survey of people living with migraine. Migraine care specialist Sait Ashina, MD, a neurologist and Director of the Comprehensive Headache Center at the Arnold-Warfield Pain Center at BIDMC, presented the survey findings at the 61st annual meeting of the American Headache Society.


How to Avoid Migraine Triggers

A migraine is a type of headache that comes with its own set of symptoms like nausea, sensitivity to light, sound or smells, extreme fatigue or dizziness. Sait Ashina, MD shares some tips on how to avoid migraine triggers.


Treating Chronic Pain With Integrative Therapies

Aditi Nerurkar, MD, Medical Director of the Cheng-Tsui Integrated Health Center at BIDMC, explains how the use of integrative therapies – such as meditation, yoga or acupuncture – in addition to some traditional therapies, can help manage chronic pain.


Revisits Have Increased Since Implementation of Program Intended to Reduce Hospital Readmissions

Researchers led by Rishi K. Wadhera, M.D., M.P.P., M.Phil., an investigator in the Smith Center for Outcomes Research in Cardiology at BIDMC, found that total 30-day hospital revisits have increased since implementation of the Hospital Readmissions Reduction Program (HRRP), a federal program implemented as part of the Affordable Care Act (ACA) in 2012 intended to address readmission rates for Medicare patients. Their analysis showed the increase in 30-day hospital revisits was due to a rise in post-discharge emergency department visits and observation stays, which on a national level, exceeded the decline in readmissions. The findings were published in the British Medical Journal.


BIDMC Prostate Health Experts Available For Interview During National Prostate Health Month (September)

About 1 in 9 men will be diagnosed with prostate cancer during their lifetime, according to the American Cancer Society. With National Prostate Health Month quickly approaching in September, BIDMC has several expert sources that may be helpful for stories you are working on now or in the future. Our experts can speak to the latest treatments options, as well as therapies currently under study in clinical trials.


BIDMC Pain Experts Available For Interview During National Pain Awareness Month (September)

Managing acute and chronic pain is a challenge for many. September is National Pain Awareness Month and BIDMC has several expert sources available for interview on various pain management topics including medication treatments, physical therapy and/or rehabilitation, behavior therapy, acupuncture and/or interventional procedures. The William Arnold-Carol A. Warfield, MD Pain Center at BIDMC includes an integrative medicine center as well as a comprehensive headache center.

Register for reporter access to contact details